The NIH Discontinues their
Drug Interaction API
Read Now!
Online
Log in
Explore
Drug Knowledgebase
Start here! Dig into essential drug information
Advanced Exploration
Categories & ATC Classifications
Pathways
Drug Reactions
Drug Classification
Drug Targets
Advanced Search
Target Sequence
Spectra Search
Pharmaco-omics
Chemical Structure
Data Library
Academic Downloads
Interaction Checker
Get More
Navigate to
DrugBank.com
to check out our commercial products, use cases and more!
DrugBank For Clinical Software
Clinical API
Clinical intelligence tool for your software
Features
Drug Search
Customizable drug search options
Drug-Drug Interaction Checker
Search for drug interactions with our API
Drug Allergy
Get drug allergy and cross sensitivities info
US Drug Labels
Integrate drug manufacturer information
Log in
Drugs
Targets
Pathways
Indications
Drugs
Drugs
Targets
Pathways
Indications
Log in or create an account for full access to this data.
Create Account
Log in
Eye Diseases
Also known as:
Eye Disease
Drug Trials
Drug
Drug Name
Drug Description
Drug
Drug Name
Target
Type
Drug
Drug Name
Phase
Status
Count
DB08885
Aflibercept
0
Completed
1
DB00305
Mitomycin
0
Completed
1
DB13262
Aceclidine
1
Completed
1
DB11105
Benzalkonium
1
Unknown Status
1
DB00484
Brimonidine
1
Completed
2
DB00091
Cyclosporine
1
Completed
1
DB00869
Dorzolamide
1
Completed
1
DB06685
Laquinimod
1
Completed
1
DB01270
Ranibizumab
1
Completed
1
DB01270
Ranibizumab
1
Terminated
1
DB00373
Timolol
1
Completed
1
DB05344
Ciliary neurotrophic factor
1 / 2
Completed
1
DB00254
Doxycycline
1 / 2
Completed
1
DB17869
QR-1123
1 / 2
Active Not Recruiting
1
DB01270
Ranibizumab
1 / 2
Completed
1
DB16327
Sepofarsen
1 / 2
Terminated
1
DB17835
Ultevursen
1 / 2
Completed
1
DB01281
Abatacept
2
Completed
1
DB13262
Aceclidine
2
Completed
2
DB08885
Aflibercept
2
Recruiting
1
DB08885
Aflibercept
2
Terminated
1
DB05288
Anecortave acetate
2
Completed
2
DB00112
Bevacizumab
2
Terminated
1
DB00484
Brimonidine
2
Completed
2
DB05028
Ocriplasmin
2
Completed
1
DB01270
Ranibizumab
2
Terminated
1
DB00313
Valproic acid
2
Completed
1
DB00083
Botulinum toxin type A
2 / 3
Unknown Status
1
DB06075
Linsitinib
2 / 3
Recruiting
2
DB16327
Sepofarsen
2 / 3
Active Not Recruiting
1
DB16327
Sepofarsen
2 / 3
Recruiting
1
DB17835
Ultevursen
2 / 3
Active Not Recruiting
1
DB17835
Ultevursen
2 / 3
Terminated
1
DB13262
Aceclidine
3
Active Not Recruiting
1
DB13262
Aceclidine
3
Completed
2
DB13262
Aceclidine
3
Recruiting
1
DB00945
Acetylsalicylic acid
3
Recruiting
1
DB08885
Aflibercept
3
Completed
1
DB08885
Aflibercept
3
Recruiting
1
DB00009
Alteplase
3
Recruiting
1
DB00484
Brimonidine
3
Active Not Recruiting
1
DB00484
Brimonidine
3
Completed
2
DB00484
Brimonidine
3
Recruiting
1
DB14864
Brolucizumab
3
Completed
1
DB00963
Bromfenac
3
Recruiting
1
DB01234
Dexamethasone
3
Recruiting
1
DB00324
Fluorometholone
3
Active Not Recruiting
1
DB00465
Ketorolac
3
Recruiting
1
DB00388
Phenylephrine
3
Completed
1
DB00388
Phenylephrine
3
Recruiting
1
DB00620
Triamcinolone
3
Recruiting
1
DB00809
Tropicamide
3
Completed
1
DB00112
Bevacizumab
4
Completed
1
DB00869
Dorzolamide
4
Completed
1
DB00654
Latanoprost
4
Completed
1
DB01270
Ranibizumab
4
Completed
1
DB00373
Timolol
4
Completed
2
DB08885
Aflibercept
Not Available
Completed
1
DB00381
Amlodipine
Not Available
Completed
1
DB00484
Brimonidine
Not Available
Completed
1
DB01194
Brinzolamide
Not Available
Completed
1
DB08818
Hyaluronic acid
Not Available
Unknown Status
1
DB00722
Lisinopril
Not Available
Completed
1
DB02709
Resveratrol
Not Available
Unknown Status
1
DB00809
Tropicamide
Not Available
Recruiting
1